COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses
Xenetic Biosciences presents promising findings on combining DNase I with CAR T cells to enhance cancer treatment strategies at the SITC Spring Scientific 2025 Cell Therapy Meeting -
COMMUNIQUÉ DE PRESSE
Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform
Aspire Biopharma Holdings, Inc. provides update on patent applications for Oral Mucosal Formulations of Aspirin with rapid absorption technology. Company aims to revolutionize drug delivery and improve patient outcomes -
-
-
COMMUNIQUÉ DE PRESSE
Prince Holding Group Earns Fifth Consecutive ‘Best in Cambodia’ Award for CSR Initiatives
Prince Holding Group recognized as 'Best in Country Excellence - Best in Cambodia' at the 17th Annual Global CSR & ESG Awards for sustainable development efforts. Awards highlight ongoing CSR and ESG initiatives guided by Chairman Chen Zhi -
COMMUNIQUÉ DE PRESSE
MIRA Pharmaceuticals Expands Ketamir-2 Development with Topical Treatment for Localized Neuropathic and Inflammatory Pain
MIRA Pharmaceuticals introduces topical Ketamir-2 for neuropathic and inflammatory pain, expanding pain management portfolio with innovative targeted approach -
-
COMMUNIQUÉ DE PRESSE
Silver X Mining Announces Closing of Brokered Private Placement for Gross Proceeds of C$3.5 Million, Which Includes A Lead Order By Palisades Goldcorp Ltd.
Silver X Mining Corp. closes a C$3,500,000 'best-efforts' private placement, including a lead order from Palisades Goldcorp Ltd., to advance operations in Nueva Recuperada Silver District, Peru -
COMMUNIQUÉ DE PRESSE
SWK Holdings Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call
SWK Holdings Corporation to announce Q4 and full year 2024 earnings results on March 19, 2025. Conference call scheduled for March 20, 2025. Company specializes in financing for healthcare companies
